Jin Medical International Ltd (NASDAQ:ZJYL) currently has a daily average trading volume of 411.92K but it saw 1705034 shares traded in last market. With a market cap of 150.81M USD, the company’s current market price of $0.96 came rising about 23.80 while comparing to the previous closing price of $0.78. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.60 and as low as $0.70. In the recent trading on the day, stock has struck highest price mark of $0.7781 while lowest mark touched by it was $1.19.
Taking a look at 20-day trading activity of Jin Medical International Ltd (ZJYL) gives us an average price of $0.8481, while its current price level is -94.20% below from 52-week high level whereas it is 37.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2870 while that of 200 days or SMA-200 reads an average of $2.5981. A closer look into the stock’s movement over the week reveals that its volatility is standing at 32.78% during that period while stretching the period over a month that decreases to 17.68%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 48.30 which implies that the stock is in neutral territory.
Over the week, ZJYL’s stock price is moving -1.69% down while it is 4.83% when we observe its performance for the past one month. Year-to-date it is 23.80% up and over the past year, the stock is showing a downside performance of -92.45%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Jin Medical International Ltd’s total number of outstanding shares is 156.55M with 75.84% of that held by the insiders while 1.15% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 11.00% and return on equity (ROE) at 11.67%. It has a price to earnings ratio (P/E ratio) of 6.25. Stock’s beta reads 13.75. Stock has a price to book (P/B) ratio of 5.75 while price to sale or P/S ratio amounts to 7.49. Its return on asset (ROA) is 8.05% on average.
